{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:06:18Z","timestamp":1787015178432,"version":"build-2736575974"},"reference-count":43,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2010,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1111\/j.1600-079x.2009.00742.x","type":"journal-article","created":{"date-parts":[[2010,1,25]],"date-time":"2010-01-25T03:32:27Z","timestamp":1264390347000},"page":"178-184","source":"Crossref","is-referenced-by-count":164,"title":["Melatonin suppresses tumor angiogenesis by inhibiting HIF-1\u03b1 stabilization under hypoxia"],"prefix":"10.1111","volume":"48","author":[{"given":"Shi-Young","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Jun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eui-Yeun","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yeong","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjin","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Won","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"issue":"Suppl. 5","key":"10.1111\/j.1600-079X.2009.00742.x-BIB1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1634\/theoncologist.9-90005-10","article-title":"The role of hypoxia-induced factors in tumor progression","volume":"9","author":"Vaupel","year":"2004","journal-title":"Oncologist"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB2","first-page":"4010","article-title":"Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth","volume":"60","author":"Ryan","year":"2000","journal-title":"Cancer Res"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jcp.10374","article-title":"How to overcome (and exploit) tumor hypoxia for targeted gene therapy","volume":"197","author":"Greco","year":"2003","journal-title":"J Cell Physiol"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB4","first-page":"941","article-title":"Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma","volume":"56","author":"Brizel","year":"1996","journal-title":"Cancer Res"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc1093","article-title":"Tumorigenesis and the angiogenic switch","volume":"3","author":"Bergers","year":"2003","journal-title":"Nat Rev"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB6","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0092-8674(02)01085-1","article-title":"Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation","volume":"111","author":"Jeong","year":"2002","journal-title":"Cell"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10555-007-9059-x","article-title":"Targeting hypoxia cell signaling for cancer therapy","volume":"26","author":"Melillo","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB8","doi-asserted-by":"crossref","first-page":"C153","DOI":"10.1016\/0303-7207(91)90087-9","article-title":"Melatonin: the chemical expression of darkness","volume":"79","author":"Reiter","year":"1991","journal-title":"Mol Cell Endocrinol"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1600-079X.2009.00701.x","article-title":"Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines","volume":"47","author":"Hardeland","year":"2009","journal-title":"J Pineal Res"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-079X.2009.00697.x","article-title":"Potential roles of melatonin and chronotherapy among the new trends in hypertension treatment","volume":"47","author":"Simko","year":"2009","journal-title":"J Pineal Res"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1600-079X.2009.00699.x","article-title":"Melatonin reduces cardiac inflammatory injury induced by acute exercise","volume":"47","author":"Veneroso","year":"2009","journal-title":"J Pineal Res"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB12","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/S0006-2952(01)00615-3","article-title":"Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3\/QR2. Tissue distribution of MT3\/QR2","volume":"61","author":"Nosjean","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/10409230903044914","article-title":"Reducing oxidative\/nitrosative stress: a newly-discovered genre for melatonin","volume":"44","author":"Reiter","year":"2009","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1600-079X.2008.00580.x","article-title":"Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species","volume":"45","author":"Peyrot","year":"2008","journal-title":"J Pineal Res"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB15","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1200\/JCO.2002.11.004","article-title":"Melatonin: from basic research to cancer treatment clinics","volume":"20","author":"Vijayalaxmi","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1748-1716.1988.tb08335.x","article-title":"Seasonal, menstrual and circadian secretions of melatonin, gonadotropins and prolactin in women","volume":"132","author":"Kivela","year":"1988","journal-title":"Acta Physiol Scand"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4103\/0019-5359.28983","article-title":"Melatonin in pathogenesis and therapy of cancer","volume":"60","author":"Ravindra","year":"2006","journal-title":"Indian J Med Sci"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-079X.2004.00165.x","article-title":"Mechanisms of cancer inhibition by melatonin","volume":"37","author":"Reiter","year":"2004","journal-title":"J Pineal Res"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB19","doi-asserted-by":"crossref","first-page":"9789","DOI":"10.1158\/0008-5472.CAN-06-1776","article-title":"Melatonin in cancer management: progress and promise","volume":"66","author":"Jung","year":"2006","journal-title":"Cancer Res"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB20","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1600-079X.2007.00424.x","article-title":"Increased vascular permeability and nitric oxide production in response to hypoxia in the pineal gland","volume":"42","author":"Kaur","year":"2007","journal-title":"J Pineal Res"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10555-007-9066-y","article-title":"Hypoxia: a key regulator of angiogenesis in cancer","volume":"26","author":"Liao","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB22","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1","volume":"16","author":"Forsythe","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB23","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB24","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB25","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.freeradbiomed.2005.05.009","article-title":"NO restores HIF-1alpha hydroxylation during hypoxia: role of reactive oxygen species","volume":"39","author":"Callapina","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB26","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.1128\/MCB.00060-08","article-title":"Reactive oxygen species regulate hypoxia-inducible factor 1alpha differentially in cancer and ischemia","volume":"28","author":"Qutub","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB27","first-page":"797","article-title":"Inhibition of cancer invasion and metastasis by targeting the molecular chaperone heat-shock protein 90","volume":"29","author":"Koga","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB28","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.bcp.2004.02.040","article-title":"New anticancer strategies targeting HIF-1","volume":"68","author":"Yeo","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB29","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.addr.2009.01.006","article-title":"The HIF-1-active microenvironment: an environmental target for cancer therapy","volume":"61","author":"Kizaka-Kondoh","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB30","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1021\/ja01543a060","article-title":"Isolation of melatonin, a pineal gland factor that lightens melanocytes","volume":"80","author":"Lerner","year":"1958","journal-title":"J Am Chem Soc"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-079X.2009.00683.x","article-title":"Evidence of immune system melatonin production by two pineal melatonin deficient mice, C57BL\/6 and Swiss strains","volume":"47","author":"Gomez-Corvera","year":"2009","journal-title":"J Pineal Res"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB32","first-page":"381","article-title":"Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT)","volume":"58","author":"Konturek","year":"2007","journal-title":"J Physiol Pharmacol"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB33","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1053\/euhj.1999.1527","article-title":"Decreased melatonin synthesis in patients with coronary artery disease","volume":"20","author":"Sakotnik","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB34","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1600-079X.2006.00375.x","article-title":"Effect and mechanism of melatonin\u2019s action on the proliferation of human umbilical vein endothelial cells","volume":"41","author":"Cui","year":"2006","journal-title":"J Pineal Res"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.critrevonc.2007.01.006","article-title":"Vascular endothelial growth factor (VEGF) signaling in tumor progression","volume":"62","author":"Roskoski","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB36","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00384-003-0576-y","article-title":"Vascular endothelial growth factor in colorectal cancer","volume":"19","author":"Guba","year":"2004","journal-title":"Int J Colorectal Dis"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1600-079X.2007.00498.x","article-title":"Melatonin modulates the expression of VEGF and HIF-1 alpha induced by CoCl2 in cultured cancer cells","volume":"44","author":"Dai","year":"2008","journal-title":"J Pineal Res"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB38","doi-asserted-by":"crossref","first-page":"25733","DOI":"10.1074\/jbc.M002740200","article-title":"Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein","volume":"275","author":"Cockman","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cmet.2005.05.002","article-title":"Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation","volume":"1","author":"Brunelle","year":"2005","journal-title":"Cell Metab"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB40","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cmet.2005.05.001","article-title":"Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing","volume":"1","author":"Guzy","year":"2005","journal-title":"Cell Metab"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB41","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cmet.2005.05.003","article-title":"Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation","volume":"1","author":"Mansfield","year":"2005","journal-title":"Cell Metab"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB42","doi-asserted-by":"crossref","first-page":"11715","DOI":"10.1073\/pnas.95.20.11715","article-title":"Mitochondrial reactive oxygen species trigger hypoxia-induced transcription","volume":"95","author":"Chandel","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1600-079X.2009.00742.x-BIB43","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1600-079X.2009.00678.x","article-title":"Melatonin down-regulates HIF-1 alpha expression through inhibition of protein translation in prostate cancer cells","volume":"46","author":"Park","year":"2009","journal-title":"J Pineal Res"}],"container-title":["Journal of Pineal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-079X.2009.00742.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-079X.2009.00742.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T09:18:00Z","timestamp":1625649480000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-079X.2009.00742.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-079x.2009.00742.x","relation":{},"ISSN":["0742-3098","1600-079X"],"issn-type":[{"value":"0742-3098","type":"print"},{"value":"1600-079X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}